PFO
STML

Pathstone Family Office’s Stemline Therapeutics, Inc. STML Stock Holding History

Pathstone Family Office’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-91
Closed -$1K – 693
2017
Q1 		$1K Buy
+91
New +$1K ﹤0.01% 551